Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia von VARTERASIAN, M. L, MOHAMMAD, R. M, AL-KATIB, A. M, EILENDER, D. S, HULBURD, K, RODRIGUEZ, D. H, PEMBERTON, P. A, PLUDA, J. M, DAN, M. D, PETTIT, G. R, CHEN, B. D. M

Volltext

Tumor Lysis Syndrome in Small Cell Carcinoma and Other Solid Tumors von Kalemkerian, Gregory P, Darwish, Bassel, Varterasian, Mary L

Volltext

Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1 von Mohammad, R M, Varterasian, M L, Almatchy, V P, Hannoudi, G N, Pettit, G R, Al-Katib, A

Volltext

Phase II Trial of Bryostatin 1 in Patients with Relapsed Low-Grade Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia von Varterasian, M L, Mohammad, R M, Shurafa, M S, Hulburd, K, Pemberton, P A, Rodriguez, D H, Spadoni, V, Eilender, D S, Murgo, A, Wall, N, Dan, M, Al-Katib, A M

Volltext

A blood stem cell transplant in a person with concomitant Hodgkin disease and testicular carcinoma von VARTERASIAN, M. L, AREF, A, KARANES, C

Volltext

Phase II study of bryostatin 1 in patients with relapsed multiple myeloma von VARTERASIAN, Mary L, PEMBERTON, Pamela A, HULBURD, Kim, RODRIGUEZ, Dorothy H, MURGO, Anthony, AL-KATIB, Ayad M

Volltext

Multicenter, Randomized Phase II Trial of Oral CI-1033 for Previously Treated Advanced Ovarian Cancer von CAMPOS, Susana, HAMID, Oday, CHARBONNEAU, Claudie, HIRTE, Hal, SEIDEN, Michael V, OZA, Amit, PLANTE, Marie, POTKUL, Ronald K, LENEHAN, Peter F, KALDJIAN, Eric P, VARTERASIAN, Mary L, JORDAN, Cheryl

Volltext

A comparative structural characterization of the human NSCL-1 and NSCL-2 genes. Two basic helix-loop-helix genes expressed in the developing nervous system von Lipkowitz, S, Göbel, V, Varterasian, M L, Nakahara, K, Tchorz, K, Kirsch, I R

Volltext

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer von HAMID, Oday, VARTERASIAN, Mary L, SHIELDS, Anthony F, WADLER, Scott, HECHT, J. Randolph, BENSON, Al III, GALANIS, Evanthia, UPRICHARD, Margaret, OMER, Charles, BYCOTT, Paul, HACKMAN, Robert C

Volltext

Non-Hodgkin's Lymphoma: An analysis of the Metropolitan Detroit SEER Database von Varterasian, Mary L., Graff, John J., Severson, Richard K., Weiss, Linda, Ai-Katib, Ayad M., Kalemkerian, Gregory P.

Volltext

Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors von Li, Yan, Mohammad, Ramzi M., Al-Katib, Ayad, Varterasian, Mary L., Chen, Ben

Volltext

Advances in the biology and treatment of multiple myeloma von Varterasian, Mary L

Volltext

Trisomy 6 as a Primary Karyotypic Aberration in Hematologic Disorders von Mohamed, Anwar N., Varterasian, Mary L., Dobin, Sheila M., McConnell, Thomas S., Wolman, Sandra R., Rankin, Cathryn, Willman, Cheryl L., Head, David R., Slovak, Marilyn L.

Volltext

Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin von MOHAMMAD, R. M, VARTERASIAN, M. L, ALMATCHY, V. P, HANNOUDI, G. N, PETTIT, G. R, AL-KATIB, A

Volltext

Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors. Commentary von LI, Y, MOHAMMAD, R. M, AL-KATIB, A, VARTERASIAN, M. L, CHEN, B, STONE, R. M

Volltext

A comparative structural characterization of the huma NSCL-1 and NSCL-2 genes : two basic helix-loop-helix genes expressed in the developing nervous system von LIPKOWITZ, S, GÖBEL, V, VARTERASIAN, M. L, NAKAHARA, K, TCHORZ, K, KIRSCH, I. R

Volltext

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies von Lorusso, Patricia M, Adjei, Alex A, Varterasian, Mary, Gadgeel, Shirish, Reid, Joel, Mitchell, David Y, Hanson, Lorelei, DeLuca, Pamela, Bruzek, Laura, Piens, Jill, Asbury, Peggy, Van Becelaere, Keri, Herrera, Roman, Sebolt-Leopold, Judith, Meyer, Mark B

Volltext

Phase I study of SYNB1891, an engineered E coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies von Luke, Jason J, Piha-Paul, Sarina A, Medina, Theresa, Verschraegen, Claire F, Varterasian, Mary, Brennan, Aoife M, Riese, Richard J, Sokolovska, Anna, Strauss, James F, Hava, David L, Janku, Filip

Volltext

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study von Sullivan, Ryan J, Infante, Jeffrey R, Janku, Filip, Wong, Deborah Jean Lee, Sosman, Jeffrey A, Keedy, Vicki, Patel, Manish R, Shapiro, Geoffrey I, Mier, James W, Tolcher, Anthony W, Wang-Gillam, Andrea, Sznol, Mario, Flaherty, Keith, Buchbinder, Elizabeth, Carvajal, Richard D, Varghese, Anna M, Lacouture, Mario E, Ribas, Antoni, Patel, Sapna P, DeCrescenzo, Gary A, Emery, Caroline M, Groover, Anna L, Saha, Saurabh, Varterasian, Mary, Welsch, Dean J, Hyman, David M, Li, Bob T

Volltext

Intratumoral Injection of Clostridium novyi -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors von Janku, Filip, Zhang, Halle Huihong, Pezeshki, Abdulmohammad, Goel, Sanjay, Murthy, Ravi, Wang-Gillam, Andrea, Shepard, Dale R, Helgason, Thorunn, Masters, Tyler, Hong, David S, Piha-Paul, Sarina A, Karp, Daniel D, Klang, Mark, Huang, Steven Y, Sakamuri, Divya, Raina, Anjali, Torrisi, Jean, Solomon, Stephen B, Weissfeld, Alice, Trevino, Ernest, DeCrescenzo, Gary, Collins, Amanda, Miller, Maria, Salstrom, Jennifer L, Korn, Ronald L, Zhang, Linping, Saha, Saurabh, Leontovich, Alexey A, Tung, David, Kreider, Brent, Varterasian, Mary, Khazaie, Khashayarsha, Gounder, Mrinal M

Volltext